674.51MMarket Cap-2764P/E (TTM)
10.250High9.970Low48.24KVolume9.970Open9.970Pre Close485.58KTurnover0.09%Turnover RatioLossP/E (Static)66.85MShares10.33952wk High1.06P/B550.92MFloat Cap6.95752wk Low0.30Dividend TTM54.60MShs Float16.706Historical High2.97%Div YieldTTM2.81%Amplitude0.179Historical Low10.065Avg Price1Lot Size
Mercer International Stock Forum
ColumnsTop upgrades and downgrades on 7/6: MRK, EOG, ABT, UNP and more
• $A.O. Smith(AOS.US)$ : Longbow Research Upgrades to Buy from Neutral - PT $71
• $Callon Petroleum(CPE.US)$ : RBC Upgrades to Outperform from Sector Perform - PT $75
• $Dun & Bradstreet(DNB.US)$ : BofA Securities Upgrades to Neutral from Underperform - PT $17 (from $16)
•$Enanta Pharmaceuticals(ENTA.US)$ : Evercore ISI Upgrades to Outperform from In Line - PT $62 (from $39)
• $Corning(GLW.US)$ : CFRA Upgrades to Strong Buy ...
The oral drug, molnupiravir, is said to ultimately stop the replication of the virus by introducing a different mechanism in the genetic material, but it could affect growing human cells.
??
No comment yet